Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Telmisartan IP 40mg + Cilnidipine IP 10mg + Metoprolol IP 50mg
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu ALu
Packaging
10x15
Price
₹229/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Telbolife Trio 50 Tablet is a triple-drug combination tablet formulated to provide comprehensive control of high blood pressure and reduce cardiovascular risk. It combines three proven classes of antihypertensive agents:
Telmisartan (an ARB) blocks angiotensin II receptors, reducing vasoconstriction and blood pressure.
Cilnidipine (a dual L/N-type calcium channel blocker) relaxes blood vessels and offers renal and vascular protection.
Metoprolol Succinate (a beta-1 selective blocker) lowers heart rate, cardiac workload, and provides cardioprotection.
This combination helps in managing resistant hypertension and reducing the risk of stroke, heart attack, and kidney complications associated with uncontrolled blood pressure.
Patients may experience mild side effects such as fatigue, dizziness, headache, slow heartbeat, or ankle swelling. In rare cases, hypotension, electrolyte imbalances, or bradycardia may occur. Serious adverse effects are uncommon but require immediate medical attention.
Telbolife Trio 50 Tablet is indicated for patients with essential hypertension who require multiple drugs to achieve target blood pressure levels. It is particularly beneficial in individuals with associated comorbidities like diabetes, chronic kidney disease, ischemic heart disease, or those at high cardiovascular risk. The combination offers synergistic antihypertensive action with organ protection and improved treatment adherence.
Use only under the supervision of a registered medical practitioner. Caution is advised in patients with liver, renal, or heart disorders. Regular monitoring of blood pressure, electrolytes, and cardiac function is recommended. Not advised during pregnancy or lactation unless directed by a physician.
Store below 25°C in a dry, cool place. Protect from direct light and moisture. Keep out of reach of children.
Composition : Telmisartan (40mg) Tablet
Composition : Telmisartan (40mg) + Amlodipine (5mg) Bilayered
Composition : Telmisartan 20 mg Tablet
Composition : Telmisartan (40mg)
Composition : Telmisartan 80mg Tablet
Composition : Telmisartan (80mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg) Tablet
Composition : Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Composition : Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 6.25mg
Composition : Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 12.5mg
Composition : Telmisartan (40mg) + Metoprolol Succinate (50mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Telbolife Trio 50 ER Tablet has strong demand in the cardiac and hypertension management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of hypertension (high blood pressure), cardiovascular risk management, and heart-related complications associated with uncontrolled BP. Telmisartan IP 40mg helps lower blood pressure by blocking angiotensin receptors Cilnidipine IP 10mg helps relax blood vessels and improve circulation Metoprolol IP 50mg helps control heart rate and reduce cardiac workload Together, this triple-combination ER tablet provides effective and long-term blood pressure control, strengthening a reliable cardiac-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Telbolife Trio 50 ER Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong cardiologist and physician prescriptions, chronic long-term therapy demand, growing market for cardiac medicines, reliable supply chain support, and good margins in cardiovascular products.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.